Literature DB >> 22002412

Factors predictive of recurrence and mortality after surgical repair of enterocutaneous fistula.

Jose L Martinez1, Enrique Luque-de-León, Guillermo Ballinas-Oseguera, José D Mendez, Marco A Juárez-Oropeza, Ruben Román-Ramos.   

Abstract

Many enterocutaneous fistulas (ECF) require operative treatment. Despite recent advances, rates of recurrence have not changed substantially. This study aims to determine factors associated with recurrence and mortality in patients submitted to surgical repair of ECF. Consecutive patients submitted to surgical repair of ECF during a 5-year period were studied. Several patient, disease, and operative variables were assessed as factors related to recurrence and mortality through univariate and multivariate analysis. There were 35 male and 36 female patients. Median age was 52 years (range, 17-81). ECF recurred in 22 patients (31%), 18 of them (82%) eventually closed with medical and/or surgical treatment. Univariate analyses disclosed noncolonic ECF origin (p = 0.04), high output (p = 0.001), and nonresective surgical options (p = 0.02) as risk factors for recurrence; the latter two remained significant after multivariate analyses. A total of 14 patients died (20%). Univariate analyses revealed risk factors for mortality at diagnosis or referral including malnutrition (p = 0.03), sepsis (p = 0.004), fluid and electrolyte imbalance (p = 0.001), and serum albumin <3 g/dl (p = 0.02). Other significant variables were interval from last abdominal operation to ECF operative treatment ≤20 weeks (p = 0.03), preoperative serum albumin <3 g/dl (p = 0.001), and age ≥55 years (p = 0.03); the latter two remained significant after multivariate analyses. Interestingly, recurrence after surgical treatment was not associated with mortality (p = 0.75). Among several studied variables, recurrence was only independently associated with high output and type of surgical treatment (operations not involving resection of ECF). Interestingly, once ECF recurred its management was as successful as non-recurrent fistulas in our series. Mortality was associated to previously-reported bad prognostic factors at diagnosis or referral.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22002412     DOI: 10.1007/s11605-011-1703-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  28 in total

1.  MANAGEMENT OF INTESTINAL FISTULAS.

Authors:  R CHAPMAN; R FORAN; J E DUNPHY
Journal:  Am J Surg       Date:  1964-08       Impact factor: 2.565

Review 2.  Open abdomen after trauma and abdominal sepsis: a strategy for management.

Authors:  William P Schecter; Rao R Ivatury; Michael F Rotondo; Asher Hirshberg
Journal:  J Am Coll Surg       Date:  2006-09       Impact factor: 6.113

3.  Small-bowel perforation complicating the open treatment of generalized peritonitis.

Authors:  W J Mastboom; H H Kuypers; F J Schoots; T Wobbes
Journal:  Arch Surg       Date:  1989-06

4.  The pathophysiology of enterocutaneous fistulas.

Authors:  J E Fischer
Journal:  World J Surg       Date:  1983-07       Impact factor: 3.352

5.  Operative strategy in the treatment of enterocutaneous fistulas.

Authors:  G L Hill
Journal:  World J Surg       Date:  1983-07       Impact factor: 3.352

6.  Management of external gastrointestinal fistulas.

Authors:  H A Reber; C Roberts; L W Way; J E Dunphy
Journal:  Ann Surg       Date:  1978-10       Impact factor: 12.969

7.  Surgical treatment of enteric 'bud' fistulas in contaminated wounds. A riskless extraperitoneal method using split-thickness skin grafts.

Authors:  I J Sarfeh; J G Jakowatz
Journal:  Arch Surg       Date:  1992-09

8.  Biological dressings for the management of enteric fistulas in the open abdomen: a preliminary report.

Authors:  Ramin Jamshidi; William P Schecter
Journal:  Arch Surg       Date:  2007-08

9.  Risk factors for recurrence after repair of enterocutaneous fistula.

Authors:  Megan Brenner; John L Clayton; Areti Tillou; Jonathan R Hiatt; H G Cryer
Journal:  Arch Surg       Date:  2009-06

10.  Treatment strategies in 135 consecutive patients with enterocutaneous fistulas.

Authors:  Ruben G J Visschers; Steven W M Olde Damink; Bjorn Winkens; Peter B Soeters; Wim G van Gemert
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

View more
  15 in total

1.  Direct bilirubin as a prognostic biomarker in enteric fistula patients complicated with sepsis: a case-control study.

Authors:  Yin Wu; Jianan Ren; Gefei Wang; Guosheng Gu; Bo Zhou; Chao Ding; Guanwei Li; Song Liu; Xiuwen Wu; Jun Chen; Jieshou Li
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Enterocutaneous Fistula: Proven Strategies and Updates.

Authors:  Irena Gribovskaja-Rupp; Genevieve B Melton
Journal:  Clin Colon Rectal Surg       Date:  2016-06

3.  Effect of Preoperative Administration of Oral Arginine and Glutamine in Patients with Enterocutaneous Fistula Submitted to Definitive Surgery: a Prospective Randomized Trial.

Authors:  Jose L Martinez; Ilka Bosco-Garate; Luis Manuel Souza-Gallardo; José D Méndez; Marco A Juárez-Oropeza; Ruben Román-Ramos; Eduardo Ferat-Osorio
Journal:  J Gastrointest Surg       Date:  2019-02-01       Impact factor: 3.452

4.  Surgery for post-operative entero-cutaneous fistulas: is bowel resection plus primary anastomosis without stoma a safe option to avoid early recurrence? Report on 20 cases by a single center and systematic review of the literature.

Authors:  A Lauro; R Cirocchi; N Cautero; A Dazzi; D Pironi; F M Di Matteo; A Santoro; S Faenza; L Pironi; A D Pinna
Journal:  G Chir       Date:  2017 Jul-Aug

Review 5.  Implications of preoperative hypoalbuminemia in colorectal surgery.

Authors:  Adam Truong; Mark H Hanna; Zhobin Moghadamyeghaneh; Michael J Stamos
Journal:  World J Gastrointest Surg       Date:  2016-05-27

6.  Effect of Oral ω3-Polyunsaturated Fatty Acids as a Complement Management to Control Fistula Output and Inflammation in Patients With Digestive Fistula.

Authors:  José Luis Martínez-Ordaz; Ilka Boscó-Gárate; Arturo Cérbulo-Vázquez; Lourdes Arriaga-Pizano; Isabel Wong-Baeza; Patricio Sánchez-Fernandez; Constantino López-Macías; Armando Isibasi; Eduardo Ferat-Osorio
Journal:  J Gastrointest Surg       Date:  2016-12-01       Impact factor: 3.452

7.  Computed Tomography-Measured Psoas Density Predicts Outcomes After Enterocutaneous Fistula Repair.

Authors:  Wilson D Lo; David C Evans; Taehwan Yoo
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-11-02       Impact factor: 4.016

8.  Risk factors, outcomes, and complications associated with combined ventral hernia and enterocutaneous fistula single-staged abdominal wall reconstruction.

Authors:  K M Klifto; S Othman; C A Messa; W Piwnica-Worms; J P Fischer; S J Kovach
Journal:  Hernia       Date:  2021-02-04       Impact factor: 4.739

9.  Complement depletion deteriorates clinical outcomes of severe abdominal sepsis: a conspirator of infection and coagulopathy in crime?

Authors:  Jianan Ren; Yunzhao Zhao; Yujie Yuan; Gang Han; Weiqin Li; Qian Huang; Zhihui Tong; Jieshou Li
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

10.  Postoperative enterocutaneous fistulas: Management outcomes in 23 consecutive patients.

Authors:  Ibrahim Falih Noori
Journal:  Ann Med Surg (Lond)       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.